Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deborah Ridout

Showing results (81-90 of 94) with videos related to

Pageof 10
Sort By:
Seizure|August 9, 2024
Maintenance of response to ketogenic diet therapy for drug-resistant epilepsy post diet discontinuation: A multi-centre case note reviewNatasha E Schoeler, Deborah Ridout, Elizabeth G Neal, et al.
Journal of Cachexia, Sarcopenia and Muscle|January 27, 2022
Investigating the role of dystrophin isoform deficiency in motor function in Duchenne muscular dystrophyMary Chesshyre, Deborah Ridout, Yasumasa Hashimoto, et al.
BMJ Open|September 11, 2019
What are the important morbidities associated with paediatric cardiac surgery? A mixed methods studyKatherine L Brown, Christina Pagel, Deborah Ridout, et al.
Plos One|June 27, 2025
Predicting trajectories of the north star ambulatory assessment total score in Duchenne muscular dystrophyFrancesco Muntoni, James Signorovitch, Nathalie Goemans, et al.
Annals of Clinical and Translational Neurology|October 10, 2020
Selenoprotein N-related myopathy: a retrospective natural history study to guide clinical trialsArpana Silwal, Anna Sarkozy, Mariacristina Scoto, et al.
Neurology|August 29, 2023
Long-term Natural History of Pediatric Dominant and Recessive <i>RYR1</i>-Related MyopathyAnna Sarkozy, Mario Sa, Deborah Ridout, et al.
Journal of Clinical Immunology|May 17, 2022
Retrospective, Landmark Analysis of Long-term Adult Morbidity Following Allogeneic HSCT for Inborn Errors of Immunity in Infancy and ChildhoodJames W Day, Reem Elfeky, Bethany Nicholson, et al.
Plos One|April 26, 2023
Determining minimal clinically important differences in the North Star Ambulatory Assessment (NSAA) for patients with Duchenne muscular dystrophyVandana Ayyar Gupta, Jacqueline M Pitchforth, Joana Domingos, et al.
Muscle & Nerve|October 4, 2021
Genotype-related respiratory progression in Duchenne muscular dystrophy-A multicenter international studyFederica Trucco, Deborah Ridout, Joana Domingos, et al.
Trials|October 11, 2021
Study of montelukast in children with sickle cell disease (SMILES): a study protocol for a randomised controlled trialAnna M Hood, Hanne Stotesbury, Melanie Kölbel, et al.
Pageof 10

Showing results (81-90 of 94) with videos related to

Sort By:
Pageof 10
Seizure|August 9, 2024
Maintenance of response to ketogenic diet therapy for drug-resistant epilepsy post diet discontinuation: A multi-centre case note reviewNatasha E Schoeler, Deborah Ridout, Elizabeth G Neal, et al.
Journal of Cachexia, Sarcopenia and Muscle|January 27, 2022
Investigating the role of dystrophin isoform deficiency in motor function in Duchenne muscular dystrophyMary Chesshyre, Deborah Ridout, Yasumasa Hashimoto, et al.
BMJ Open|September 11, 2019
What are the important morbidities associated with paediatric cardiac surgery? A mixed methods studyKatherine L Brown, Christina Pagel, Deborah Ridout, et al.
Plos One|June 27, 2025
Predicting trajectories of the north star ambulatory assessment total score in Duchenne muscular dystrophyFrancesco Muntoni, James Signorovitch, Nathalie Goemans, et al.
Annals of Clinical and Translational Neurology|October 10, 2020
Selenoprotein N-related myopathy: a retrospective natural history study to guide clinical trialsArpana Silwal, Anna Sarkozy, Mariacristina Scoto, et al.
Neurology|August 29, 2023
Long-term Natural History of Pediatric Dominant and Recessive <i>RYR1</i>-Related MyopathyAnna Sarkozy, Mario Sa, Deborah Ridout, et al.
Journal of Clinical Immunology|May 17, 2022
Retrospective, Landmark Analysis of Long-term Adult Morbidity Following Allogeneic HSCT for Inborn Errors of Immunity in Infancy and ChildhoodJames W Day, Reem Elfeky, Bethany Nicholson, et al.
Plos One|April 26, 2023
Determining minimal clinically important differences in the North Star Ambulatory Assessment (NSAA) for patients with Duchenne muscular dystrophyVandana Ayyar Gupta, Jacqueline M Pitchforth, Joana Domingos, et al.
Muscle & Nerve|October 4, 2021
Genotype-related respiratory progression in Duchenne muscular dystrophy-A multicenter international studyFederica Trucco, Deborah Ridout, Joana Domingos, et al.
Trials|October 11, 2021
Study of montelukast in children with sickle cell disease (SMILES): a study protocol for a randomised controlled trialAnna M Hood, Hanne Stotesbury, Melanie Kölbel, et al.
Pageof 10